Atsuko Nakatsuka

2.9k citations

50 papers · 2.2k indexed · 2 hit papers · h-index 20

Endocrine and Autonomic Systems top 5%
Endocrinology, Diabetes and Metabolism top 2%
Nephrology top 5%
- Chronic Kidney Disease and Diabetes 4
Physiology top 5%
- Adipose Tissue and Metabolism 7
Epidemiology top 5%
- Adipokines, Inflammation, and Metabolic Diseases 6
- Liver Disease Diagnosis and Treatment 5
Surgery
- Pancreatic function and diabetes 9
Genetics
- Diabetes and associated disorders 6
Cell Biology
- Endoplasmic Reticulum Stress and Disease 6
Immunology
- Galectins and Cancer Biology 5

Co-authors: Jun Wada Jun Eguchi Hirofumi Makino Sanae Teshigawara Kazuyuki Hida Daisuke Ogawa Kazutoshi Murakami Akihiro Katayama
Cited by: Endocrine and Autonomic Systems Endocrinology, Diabetes and Metabolism Nephrology
Journals: Proceedings of the National Academy of Sciences (1 paper)Circulation (1 paper)PLoS ONE (4 papers)
Partner nations: Japan United States Canada

In The Last Decade

Atsuko Nakatsuka

48 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Atsuko Nakatsuka

Since Specialization

Citations

This map shows the geographic impact of Atsuko Nakatsuka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsuko Nakatsuka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsuko Nakatsuka more than expected).

Fields of papers citing papers by Atsuko Nakatsuka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsuko Nakatsuka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsuko Nakatsuka. The network helps show where Atsuko Nakatsuka may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Atsuko Nakatsuka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Atsuko Nakatsuka Line = papers co-authored together Atsuko Nakatsuka links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Inhibition of Amino Acids Influx into Proximal Tubular Cells Improves Lysosome Function in Diabetes Kidney360 ·Yuzuki Kano,Satoshi Yamaguchi,Koki Mise,Chieko Kawakita,Yasuhiro Onishi,Naoko Kurooka,Ryosuke Sugawara,Haya Hamed Hassan Albuayjan,Atsuko Nakatsuka,Jun Eguchi,Jun Wada	2023	3
2	Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2 Scientific Reports ·Tomokazu Nunoue,Satoshi Yamaguchi,Sanae Teshigawara,Akihiro Katayama,Atsuko Nakatsuka,Jun Eguchi,Toshiro Niki,Jun Wada	2021	3
3	Dysfunction of CD8 + PD-1 + T cells in type 2 diabetes caused by the impairment of metabolism-immune axis Scientific Reports ·Ichiro Nojima,Shingo Eikawa,Nahoko Tomonobu,Yoshiko Hada,Nobuo Kajitani,Sanae Teshigawara,Satoshi Miyamoto,Atsuhito Tone,Haruhito A. Uchida,Atsuko Nakatsuka,Jun Eguchi,Kenichi Shikata,Heiichiro Udono,Jun Wada	2020	38
4	The hypoglycemia-prevention effect of sensor-augmented pump therapy with predictive low glucose management in Japanese patients with type 1 diabetes mellitus: a short-term study Diabetology International ·Akihiro Katayama,Atsuhito Tone,Mayu Watanabe,Sanae Teshigawara,Satoshi Miyamoto,Jun Eguchi,Atsuko Nakatsuka,Kenichi Shikata,Jun Wada	2019	7
5	GPIHBP1 autoantibody syndrome during interferon β1a treatment Journal of clinical lipidology ·Jun Eguchi,Kazuya Miyashita,Isamu Fukamachi,Katsuyuki Nakajima,Masami Murakami,Yuko Kawahara,Toru Yamashita,Yasuyuki Ohta,Koji Abe,Atsuko Nakatsuka,M. Mino,Satoru Takase,Hiroaki Okazaki,Robert A. Hegele,Michael Ploug,Xuchen Hu,Jun Wada,Stephen G. Young,Anne P. Beigneux	2018	15
6	Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: two case reports Journal of Medical Case Reports ·Yusuke Shibata,Atsuko Nakatsuka,Jun Eguchi,Satoshi Miyamoto,Yukari Masuda,Motoharu Awazawa,Akinobu Takaki,Ryuichi Yoshida,Takahito Yagi,Jun Wada	2018	9
7	Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis Scientific Reports ·Atsuko Nakatsuka,Makoto Matsuyama,Satoshi Yamaguchi,Akihiro Katayama,Jun Eguchi,Kazutoshi Murakami,Sanae Teshigawara,Daisuke Ogawa,Nozomu Wada,Tetsuya Yasunaka,Fusao Ikeda,Akinobu Takaki,Eijiro Watanabe,Jun Wada	2016	46
8	Translocase of inner mitochondrial membrane 44 alters the mitochondrial fusion and fission dynamics and protects from type 2 diabetes Metabolism ·Yu Wang,Akihiro Katayama,Takahiro Terami,Xiaoying Han,Tomokazu Nunoue,Dongxiao Zhang,Sanae Teshigawara,Jun Eguchi,Atsuko Nakatsuka,Kazutoshi Murakami,Daisuke Ogawa,Yasuhide Furuta,Hirofumi Makino,Jun Wada	2015	21
9	Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitis Scientific Reports ·Akihiro Katayama,Atsuko Nakatsuka,Jun Eguchi,Kazutoshi Murakami,Sanae Teshigawara,Motoko Kanzaki,Tomokazu Nunoue,Kazuyuki Hida,Nozomu Wada,Tetsuya Yasunaka,Fusao Ikeda,Akinobu Takaki,Kazuhide Yamamoto,Hiroshi Kiyonari,Hirofumi Makino,Jun Wada	2015	62
10	Serum vaspin levels are associated with physical activity or physical fitness in Japanese: a pilot study Environmental Health and Preventive Medicine ·Nobuyuki Miyatake,Jun Wada,Atsuko Nakatsuka,Noriko Sakano,Sanae Teshigawara,Motohiko Miyachi,Izumi Tabata,Takeyuki Numata	2014	4
11	Nuclear Hormone Receptor Expression in Mouse Kidney and Renal Cell Lines PLoS ONE ·Daisuke Ogawa,Jun Eguchi,Jun Wada,Naoto Terami,Takashi Hatanaka,Hiromi Tachibana,Atsuko Nakatsuka,Chikage Sato Horiguchi,Naoko Nishii,Hirofumi Makino	2014	13
12	Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Micebreakdown → PLoS ONE ·Naoto Terami,Daisuke Ogawa,Hiromi Tachibana,Takashi Hatanaka,Jun Wada,Atsuko Nakatsuka,Jun Eguchi,Chikage Sato Horiguchi,Naoko Nishii,Hiroshi Yamada,Kohji Takei,Hirofumi Makino	2014	294
13	Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease BMC Nephrology ·Yuko Kurose,Jun Wada,Motoko Kanzaki,Sanae Teshigawara,Atsuko Nakatsuka,Kazutoshi Murakami,Kentaro Inoue,Takahiro Terami,Akihiro Katayama,Mayu Watanabe,Chigusa Higuchi,Jun Eguchi,Nobuyuki Miyatake,Hirofumi Makino	2013	52
14	Urinary Fetuin-A Is a Novel Marker for Diabetic Nephropathy in Type 2 Diabetes Identified by Lectin Microarray PLoS ONE ·Kentaro Inoue,Jun Wada,Jun Eguchi,Atsuko Nakatsuka,Sanae Teshigawara,Kazutoshi Murakami,Daisuke Ogawa,Takahiro Terami,Akihiro Katayama,Atsuhito Tone,Izumi Iseda,Kazuyuki Hida,Masao Yamada,Tomohisa Ogawa,Hirofumi Makino	2013	49
15	A Case of Type 2 Diabetes and Metastatic Liver Cancer Exhibiting Hypercholesterolemia with Abnormal Lipoproteins Internal Medicine ·Motoko Kanzaki,Jun Wada,Atsuko Nakatsuka,Sanae Teshigawara,Kazutoshi Murakami,Kentaro Inoue,Takahiro Terami,Akihiro Katayama,Junichiro Nasu,Kazuhide Yamamoto,Hirofumi Makino	2012	1
16	RXR antagonism induces G0/G1 cell cycle arrest and ameliorates obesity by up-regulating p53-p21Cip1 pathway in adipocytes Okayama Igakkai Zasshi (Journal of Okayama Medical Association) ·Atsuko Nakatsuka,Jun Wada,Hirofumi Makino	2012	0
17	Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice Hepatology ·Daisuke Kawai,Akinobu Takaki,Atsuko Nakatsuka,Jun Wada,Naofumi Tamaki,Tetsuya Yasunaka,Kazuko Koike,Ryuichiro Tsuzaki,Kazuyuki Matsumoto,Yasuhiro Miyake,Hidenori Shiraha,Manabu Morita,Hirofumi Makino,Kazuhide Yamamoto	2012	109
18	RXR antagonism induces G₀/G₁ cell cycle arrest and ameliorates obesity by up‐regulating the p53–p21$^{\rm{Cip1}}$ pathway in adipocytes The Journal of Pathology ·Atsuko Nakatsuka,Jun Wada,Kazuyuki Hida,Aya Hida,Jun Eguchi,Sanae Teshigawara,Kazutoshi Murakami,Motoko Kanzaki,Kentaro Inoue,Takahiro Terami,Akihiro Katayama,Daisuke Ogawa,Hiroyuki Kagechika,Hirofumi Makino	2011	21
19	Collectrin Is Involved in the Development of Salt-Sensitive Hypertension by Facilitating the Membrane Trafficking of Apical Membrane Proteins via Interaction With Soluble N -Ethylmaleiamide-Sensitive Factor Attachment Protein Receptor Complex Circulation ·Akihiro Yasuhara,Jun Wada,Sandra M. Malakauskas,Yanling Zhang,Jun Eguchi,Atsuko Nakatsuka,Kazutoshi Murakami,Motoko Kanzaki,Sanae Teshigawara,Kazuya Yamagata,Thu H. Le,Hirofumi Makino	2008	24
20	A case of monoclonal immunoglobulin light- and heavy-chain deposition disease exhibiting atypical deposition with fibrillary structures, successfully treated with chemotherapy Clinical Nephrology ·Atsuko Nakatsuka,Yohei Maeshima,A. Sarai,Hiroyuki Yanai,Hitoshi Sugiyama,Yasushi Yamasaki,H Makino	2005	4

About Atsuko Nakatsuka

Atsuko Nakatsuka is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Clinical Biochemistry, having authored 50 papers that have together received 2.2k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (9 papers), Adipose Tissue and Metabolism (7 papers), Diabetes and associated disorders (6 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers), Endoplasmic Reticulum Stress and Disease (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Galectins and Cancer Biology (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). The work is most often cited by research in Endocrine and Autonomic Systems (183 citations), Endocrinology, Diabetes and Metabolism (448 citations) and Nephrology (171 citations). Atsuko Nakatsuka has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Jun Wada, Jun Eguchi, Hirofumi Makino, Sanae Teshigawara, Kazuyuki Hida, Daisuke Ogawa, Kazutoshi Murakami, Akihiro Katayama, Motoko Kanzaki and Ryuji Hiramatsu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Circulation and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact